Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $120.1150 (-2.35%) ($119.1700 - $120.1150) on Wed. May. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 26 | Latest Price | $120.1150(-2.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -5.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -1.73% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) IGOV(-6%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $112.63(-6.23%) | Resistance Level | $134.55 | 5 Day Moving Average | $124.56(-3.57%) | 10 Day Moving Average | $126.08(-4.73%) | 20 Day Moving Average | $134.55(-10.73%) | To recent high | -27.6% | To recent low | 0% | Market Cap | $1.93b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |